Non-Small-Cell Lung Cancer [Afatinib (Gilotrif) (Wave 2)] | LaunchTrends | US | 2014

Please be advised that recently there have been fraudulent job offers and interviews using the Clarivate name, logo and even names of our colleagues.

Please be aware that Clarivate will:

• Never ask for payment of any kind as part of our hiring or onboarding processes
• Never ask an applicant to email sensitive personal information, such as a Social Security Number, birthdate, credit card or bank account information
• Never issue pre-employment checks to purchase office supplies
• Never ask you to pay up for an external course and upskill

If you have any question about a position posted in our company name, please check our current open positions on the Clarivate website Careers pages or contact one of our recruiting team members directly.

If you have been the victim of a scam, please contact your local law enforcement agency.

This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine-readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.